nhia logo

 

      contact us

Latest News

NHIA Restates Concerns to Hill About 21st Century Cures' Imposed Gap in Reimbursement

November 30, 2016

CMS Releases 2017 Round 1 DMEPOS Competitive Bidding Contracts

November 1, 2016

Study Shows Home Environment Does Not Increase Catheter Complications

November 1, 2016

CMS Releases Final 2017 Payments for Home Health Agencies

October 31, 2016

AA Homecare Study Points to Medicare Competitive Bidding Rates Below Provider Costs

October 31, 2016

FDA Releases Guidance on REMS

October 24, 2016

HHS Finalizes New Physician Payment Program

October 24, 2016

 

Medicare Home Infusion Legislation Gains New Senate Co-Sponsor 

Encourage your elected representatives to  co-sponsor the Medicare Home Infusion Site of Care Act now!

October 11, 2016

NIOSH Releases Updated List of Hazardous Drugs in Healthcare Settings

Review the list, which supersedes the 2014 publication

October 10, 2016

U.S. Pharmacopeial Convention Posts FAQs on USP <800>

Read the FAQs prepared by the USP Compounding Expert Committee

October 10, 2016

INS Publishes List of Noncytotoxic Vesicant Medications

Includes extravasation checklist. Read more.

October 10, 2016

NHIA Responds To OIG Report on Part B DME Infusion Drugs and Switch to ASP

September 15, 2016

New DME Advisory Council Q&A Document Sheds Light on Medicare DME MAC Infusion Pump Billing.

September 7, 2016

 

NHIA Working for You!

NHIA Foundation Participates in #GivingTuesday

NHIA Now Accepting Nominations for Gene Graves Award

November 8, 2016

NHIA Nov. 3 Webinar: FDA Inspections - Preparing and Protecting Your Home Infusion Pharmacy

NHIA Members: Access slides and presentation

November 7, 2016

NHIA Comments on FDA Draft Guidance on Compounding Drug Products

NHIA submitted comments to the U.S. Food and Drug Administration (FDA) on the agency's draft guidance regarding "compounding drug products that are essentially copies of commercially available drug product under 503A. Read the comments.

October 11, 2016

 

 

NHIA Comments on FDA Draft Guidance on Compounding Facilities

NHIA submitted comments to the U.S. Food and Drug Administration (FDA) on the agency's draft guidance regarding "insanitary conditions at compounding facilities." Read the comments.

October 3, 2016

NHIA Signs On to Letters Sent to Hill and FDA on Compounding Pharmacy 

Read the letters to Congress and the FDA.

September 28, 2016

ASP Drug Pricing Advocacy Center—Ways to Get Involved

 

Provisder Portal

NHIA Strategic Leadership

membership icon = Member Only

NHIA Member-Only Resource Centers

Drug Shortage Resource Center

HIPAA NPI Resource Center

HIPAA Final Omnibus Rule Resource Center

Legislative & Advocacy Resource Center

Accreditation Resource Center

Reimbursement Resource Center

Sterile Compounding Resource Center

 

NHIA Vital Information

membership icon = Member Only

email

 

 

 

Membership

Be a part of the infusion field

Join NHIA Now!Update your membership
Latest Issue of INFUSION

infusion

Tools
Search NHIA.org


hill day